Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
44 studies found for:    " May 26, 2010":" June 25, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" May 26, 2010":" June 25, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed
Has Results
Biobehavioral Interventions for HIV-negative, Stimulant Using Men Who Have Sex With Men
Conditions: HIV Seroconversion;   Stimulant Abuse
Intervention: Drug: Truvada
2 Unknown  Complementary & Alternative Medicine Use in HIV+ Latinos in the US-Mexico Border
Condition: HIV Positive
3 Completed A Pivotal Study to Assess the Safety and Efficacy of The PrePex System, a Male Circumcision Device and Methodology for Rapid Scale up of Painless and Bloodless National Circumcision Programs, in Urban and Remote Rural Settings
Conditions: Male Circumcision;   HIV Prevention;   HIV Infections
Intervention: Device: The PrePex a novel device for adult male circumcision
4 Unknown  Comparative Effectiveness of Web-based Versus Traditional Adolescent HIV Prevention
Conditions: HIV Infections;   Hepatitis;   Sexually Transmitted Infections
Interventions: Behavioral: Traditional Prevention;   Behavioral: Web-based Prevention
5 Completed Pharmacokinetics of Low Dose Raltegravir
Condition: HIV Infections
Intervention: Drug: raltegravir
6 Active, not recruiting Tenofovir Renal Toxicity and Glomerular Filtration Rate (GFR) Validation
Conditions: Renal Function;   HIV Infection
Intervention: Other: Tc99mDTPA renal clearance
7 Completed
Has Results
Efficacy Against TB Disease, Safety, and Immunogenicity of MVA85A/AERAS-485 in HIV-Infected Adults (C-030-485)
Conditions: Tuberculosis;   HIV Infections
Interventions: Biological: MVA85A/AERAS-485;   Biological: Placebo
8 Completed
Has Results
Clinical Study of TUTI-16 in HIV-1 Infected and Uninfected Subjects
Condition: HIV Infections
Interventions: Biological: TUTI-16 (0.2mg);   Biological: TUTI-16 (1.0 mg)
9 Completed Metabolic and Psychological Changes Associated With Menopause Among Women With HIV
Conditions: HIV Infections;   Menopause
10 Completed Pharmacokinetics (PK) and Safety of 2 Different Doses of Lopinavir/Ritonavir in in HIV/Tuberculosis (TB) Co-infected Patients Receiving Rifampicin Containing Anti-tuberculosis Therapy
Conditions: HIV Infections;   Tuberculosis
Intervention: Drug: LPV/r
11 Active, not recruiting Hepatic Safety of Raltegravir Versus Efavirenz as HIV Therapy for Patients With HIV and HCV Coinfection
Conditions: Hepatitis C, Chronic;   HIV Infection
Interventions: Drug: Raltegravir;   Drug: Efavirenz
12 Completed Novel Measures and Theory of Pediatric Antiretroviral Therapy Adherence in Uganda
Condition: HIV-infection/Aids
13 Completed The Immunogenicity of Varicella-zoster Virus Vaccine in HIV-infected Children
Conditions: HIV Infections;   Varicella-Zoster Virus
Intervention: Biological: VZV vaccination
14 Completed Male Involvement in Antenatal Care and the Prevention Programme of Mother-to-child Transmission of HIV in Uganda
Condition: HIV Infection
Interventions: Behavioral: Invitation letter for male spouse;   Behavioral: Information letter
15 Completed
Has Results
Treatment Options for Protease Inhibitor-exposed Children
Conditions: HIV/AIDS;   HIV Infections
Interventions: Drug: Efavirenz (EFV);   Drug: Lopinavir/ritonavir (LPV/r);   Drug: Stavudine (D4T);   Drug: Abacavir (ABC)
16 Completed Low Dose Atazanavir/r Versus Standard Dose Atazanavir/r (LASA)
Condition: HIV Infections
Intervention: Drug: ATV/r
17 Recruiting Selective Exposure in HIV Prevention
Condition: HIV Infections
Interventions: Other: Instrumental meta intervention;   Other: Empowering meta-intervention;   Other: Control
18 Completed A Safety Study to Assess the Delivery of Dapivirine From a Matrix Vaginal Ring
Condition: HIV Infections
Interventions: Drug: dapivirine;   Drug: placebo
19 Completed Pharmacogenomic of Atazanavir/Efavirenz (ATV/EFV)
Condition: HIV Infections
20 Completed Tenofovir Gel in Pregnancy and Lactation
Condition: HIV Infections
Interventions: Drug: Tenofovir 1% gel;   Other: Placebo gel

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years